JP2015536347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536347A5 JP2015536347A5 JP2015542821A JP2015542821A JP2015536347A5 JP 2015536347 A5 JP2015536347 A5 JP 2015536347A5 JP 2015542821 A JP2015542821 A JP 2015542821A JP 2015542821 A JP2015542821 A JP 2015542821A JP 2015536347 A5 JP2015536347 A5 JP 2015536347A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- residues
- acid sequence
- mtre
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261727451P | 2012-11-16 | 2012-11-16 | |
| US61/727,451 | 2012-11-16 | ||
| PCT/US2013/070310 WO2014078656A1 (en) | 2012-11-16 | 2013-11-15 | Gonorrheal mtre peptides and vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015536347A JP2015536347A (ja) | 2015-12-21 |
| JP2015536347A5 true JP2015536347A5 (enExample) | 2017-01-05 |
Family
ID=50731717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542821A Pending JP2015536347A (ja) | 2012-11-16 | 2013-11-15 | 淋菌性ＭｔｒＥペプチドおよびワクチン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9902756B2 (enExample) |
| EP (1) | EP2919806A4 (enExample) |
| JP (1) | JP2015536347A (enExample) |
| AU (1) | AU2013344571A1 (enExample) |
| CA (1) | CA2891552A1 (enExample) |
| WO (1) | WO2014078656A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10286016B2 (en) | 2014-09-02 | 2019-05-14 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating gonorrhea |
| US10900043B2 (en) | 2014-09-02 | 2021-01-26 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating bacterial disease |
| CA3035320A1 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
| MX2023003007A (es) * | 2020-09-17 | 2023-04-10 | Prothena Biosciences Ltd | Vacuna de sinucleina alfa para el tratamiento de sinucleinopatias. |
| GB202214756D0 (en) * | 2022-10-07 | 2022-11-23 | Univ Oxford Innovation Ltd | Product |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1007730A4 (en) | 1996-08-30 | 2004-04-28 | Invitrogen Corp | METHODS OF IDENTIFYING AND ISOLATING SPECIFIC NUCLEOTIDE SEQUENCES IN cDNA AND GENOMIC DNA |
| CN100379757C (zh) * | 1998-05-01 | 2008-04-09 | 希龙公司 | 脑膜炎奈瑟球菌抗原和组合物 |
| JP2001011096A (ja) * | 1999-06-28 | 2001-01-16 | Maruho Co Ltd | 淋菌に対するヒト抗体 |
| PT2275551E (pt) * | 1999-10-29 | 2015-06-29 | Novartis Vaccines & Diagnostic | Péptidos antigénicos de neisseria |
| GB0103424D0 (en) | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| EP2542686B1 (en) | 2010-03-01 | 2018-01-03 | Seikagaku Corporation | Compositions and methods for bacterial production of chondroitin |
-
2013
- 2013-11-15 US US14/442,832 patent/US9902756B2/en active Active
- 2013-11-15 EP EP13855714.5A patent/EP2919806A4/en not_active Withdrawn
- 2013-11-15 JP JP2015542821A patent/JP2015536347A/ja active Pending
- 2013-11-15 WO PCT/US2013/070310 patent/WO2014078656A1/en not_active Ceased
- 2013-11-15 CA CA2891552A patent/CA2891552A1/en not_active Abandoned
- 2013-11-15 AU AU2013344571A patent/AU2013344571A1/en not_active Abandoned
-
2018
- 2018-02-26 US US15/905,479 patent/US10414805B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005120106A5 (enExample) | ||
| JP2011004753A5 (enExample) | ||
| JP2018520654A5 (enExample) | ||
| JP2010273685A5 (enExample) | ||
| CN108707620A (zh) | 一种Gene drive载体及构建方法 | |
| Krishnan | Pilins in Gram‐positive bacteria: a structural perspective | |
| JP2018198596A5 (enExample) | ||
| JP2011224002A5 (enExample) | ||
| JP2015536347A5 (enExample) | ||
| JP2012000112A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| JP2012126742A5 (enExample) | ||
| JP2013530689A5 (enExample) | ||
| JP2015523066A5 (enExample) | ||
| CN110036108A (zh) | 一种细菌β-1,3-葡聚糖酶及其编码基因与应用 | |
| JP2013531491A5 (enExample) | ||
| JP2013516991A5 (enExample) | ||
| JP2013531967A5 (enExample) | ||
| CN102942624B (zh) | 一种半乳糖凝集素-3结合蛋白及其制备和应用 | |
| WO2020057742A1 (en) | Vaccine and antibody against clostidioides difficile toxin | |
| CN104474557A (zh) | 一种具有抑菌活性的长牡蛎C型凝集素-2(CgCLec-2)重组蛋白的应用 | |
| CN102241759B (zh) | 一种抑菌性铁蛋白及其制备和应用 | |
| RU2011134436A (ru) | Способ получения l-аминокислоты с использованием бактерии семейства enterobacteriaceae, обладающей повышенной экспрессией генов каскада образования флагелл и клеточной подвижности | |
| JP2016535071A5 (enExample) | ||
| EA201391669A1 (ru) | Белок f - новый адгезин haemophilus influenzae, способный связывать ламинин и витронектин |